Cardama Alfonso Quintas 4
4 · Foghorn Therapeutics Inc. · Filed Sep 13, 2023
Insider Transaction Report
Form 4
Cardama Alfonso Quintas
Chief Medical Officer
Transactions
- Award
Stock Options (Right to buy)
2023-09-11$7.57/sh+272,000$2,059,040→ 272,000 totalExercise: $7.57Exp: 2033-09-10→ Common Stock (272,000 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the underlying shares of common stock on September 11, 2024, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter until the option is fully vested.